[ad_1]
Ovarian cancer life expectancy is influenced by factors such as the stage, type of cell affected, and differentiation of cancer cells. Early detection and treatment can lead to a good prognosis, with a 90% survival rate for stage 1 cancer, while stage 4 cancer has a significantly reduced survival rate. Differentiated cells are easier to treat, while poorly differentiated tumors spread rapidly, giving patients less chance of survival.
There are a number of factors that can affect a patient’s ovarian cancer life expectancy. Ovarian tumors can be evaluated based on the type of cell affected, the differentiation of cancer cells and the stage of the cancer, all of which influence a patient’s chances of beating the cancer. In most cases, this type of cancer can go into complete remission, in which case life expectancy is good. After five years of remission, the cancer is considered treated and the patient’s life expectancy is no longer affected by the disease.
Doctors will examine the tumor in a case of ovarian cancer to learn more about the specifics of the cancer in any particular patient. No two types of cancer behave exactly alike, and knowing the structure of the cancerous tumor helps medical professionals develop a specific course of treatment for each particular woman’s needs. Once they know a little more about cancer cells, doctors are able to talk to their patients about their ovarian cancer life expectancy.
For the most part, ovarian cancer is considered curable, meaning the patient can expect a full recovery. Tumors that are caught in their early stages, before they have entered nearby tissue, are the easiest to treat. The life expectancy of a patient with stage 1 cancer is good and 90% of patients will survive beyond five years. Patients with stage 2 or stage 3 cancer can be expected to survive, although only about 70% of patients in these stages make it to the five-year mark. In a patient with widespread stage 4 cancer, the life expectancy of ovarian cancer is significantly reduced and only 30% of the patients are cancer survivors.
The life expectancy of ovarian cancer can also be influenced by the type of cells in the tumor. Well-differentiated cells are easier to kill and also grow at a slower rate, which gives doctors more time to treat disease. In these cases, a patient’s life expectancy is very good. Poorly differentiated tumors spread rapidly, which gives patients with this type of cancer cells less chance of survival. Clear cell and mucinous tumors are also more difficult to treat than germ cell tumors or sex cord stromal tumors.
[ad_2]